Medtronic (NYSE:MDT) announced today that it expanded U.S. pharmacy formulary access for its MiniMed 780G insulin pump.

Medtronic disclosed Diabetes unit executive pay packages for 2025 and compensation targets for when they'll lead MiniMed as a ...

Medtronic’s planned diabetes device spinoff MiniMed has filed for an initial public offering, the company said Friday. The filing shows MiniMed made a $198 million loss on sales of $2.72 billion in ...

MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet. Medtronic announced in May that it would spin off its diabetes business into a ...

ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Point-of-care infectious disease diagnostics valued at $53 billion in ...